Table of Contents: CATIE News - 2000
Canadian AIDS Treatment Information Exchange
Edited by: Alan Boutilier and Sean Hosein

Table Of Contents

December
Can an old anti-parasite drug fight TB?; More caution with nevirapine; Caution advised when using Cipro with methadone; Transplanted organs from animals? Have your say; Is once daily indinavir with ritonavir on the way?; Vitamin cocktail helps people recover from nuke side effects
November
New treatment for hepatitis C approved in Canada
September
Methadone interferes with some formulations of ddI; Approval sought for new ddI capsules; A note about ICAAC; ICAAC: Nelfinavir interacts with statins and an anti-seizure drug; ICAAC: News on cervical and oral HPV lesions as well as a possible new treatment; ICAAC: L-carnitine for lipodystrophy syndrome;
August
Cidofovir reported useful for mollusca lesions in kids; Supplement found to boost production of anti-HIV chemicals; Can acupuncture help overcome cocaine addiction?;Warning about ddI dosing; Protease inhibitors interact with some sleeping pills; Viagra: Caution with ritonavir and saquinavir; Fluconazole boosts fluvastatin levels; Zinc and the common cold
July
Update on ABT-378; Durban AIDS conferences heralds major changes in HIV/AIDS therapy?;
June
HIV-hepatitis study yields promising results for some; Prevalence of drug resistance high; Guidelines for managing dyslipidemia on the Web
May
KS drug approved in Canada; A warning about amprenavir oral solution; L-acetylcarnitine improves drug-related neuropathy;
April
Link tightens between PIs and bone mineral density loss; European Union issues safety warning about nevirapine
March
Smoking appears more harmful to people with HIV; Adherence study now recruiting in Toronto; Amprenavir dose reduction for people with liver disease
February
Hepatitis C overview; Combination therapy for hepatitis C; A simpler form of interferon for hepatitis C; Updated treatment guidelines for adolescents and adults available on the Web; Risk of nerve damage with ddI/d4T/hydroxyurea; A potentially harmful interaction between indinavir and St. John's wort; Structured treatment interruptions -- More study required
January
Liver toxicity and antiretrovirals; New drug promises triple therapy in a single pill; Updated treatment guidelines on the Web; Lactic acidosis linked to d4T; Abacavir warning revised; Retroviruses conference under way
Copyright / Funding / How to reach CATIE
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2000. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.